Company / Accounts Receivable
PROCEPT BioRobotics Corp Accounts Receivable History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$83.5M
FY2025
5-year range
$4.5M / $83.5M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#103 of 138
Health Care
What the data says
PROCEPT BioRobotics Corp's accounts receivable of $84M is lower than 75% of companies in the Health Care sector (FY2025). Accounts Receivable has increased for 5 consecutive years, from $2M in FY2020 to $84M in FY2025.
Based on SEC 10-K filings.
$84M in FY2025 with a 5-year CAGR of +122.0%.
Improved from $48M to $84M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +76.2%
- 5-Year CAGR
- +122.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 138This company $83.5M Sector average $1.4B
▼
-93.9% below sector average
Key checks
Key Insights
- PROCEPT BioRobotics Corp's accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +122.0%, indicating consistent growth.
- In FY2025, accounts receivable increased 0.0% year-over-year.
- Ranks #103 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.5M | +0.0% |
| FY2024 | $83.5M | +72.6% |
| FY2023 | $48.4M | +216.8% |
| FY2022 | $15.3M | +242.1% |
| FY2021 | $4.5M | +188.2% |
| FY2020 | $1.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026